Start for free
Start for free
HW

Hansjörg Wyss

Description

Hansjörg Wyss - CEO @ Opsonix

Investor Profile

Hansjörg Wyss has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Health Care
  • Life Science
  • Advanced Materials
  • Building Material
  • Chemical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Hansjörg Wyss frequently co-invest with?

BASF Venture Capital
BASF Venture Capital
Europe, Rheinland-Pfalz, Germany, Ludwigshafen
Co-Investments: 1
ATEL Ventures
ATEL Ventures
North America, California, United States, San Francisco
Co-Investments: 1
OS Fund
OS Fund
North America, Illinois, United States, Chicago
Co-Investments: 1
Cedars Sinai
Cedars Sinai
North America, California, United States, Los Angeles
Co-Investments: 1
CSC Upshot
CSC Upshot
North America, California, United States, Palo Alto
Co-Investments: 1
Techammer
Techammer
North America, New York, United States, New York
Co-Investments: 1
ALS Finding a Cure
ALS Finding a Cure
North America, Florida, United States, Boynton Beach
Co-Investments: 1
+ND Capital
+ND Capital
North America, California, United States, San Mateo
Co-Investments: 1
Massachusetts Clean Energy Center
Massachusetts Clean Energy Center
North America, Massachusetts, United States, Boston
Co-Investments: 1
Anzu Partners
Anzu Partners
North America, District of Columbia, United States, Washington
Co-Investments: 1

What are some of recent deals done by Hansjörg Wyss?

ReadCoor

Cambridge, Massachusetts, United States

Leader in true multi-omic spatial sequencing

BiotechnologyMedicalPharmaceutical
Series BJan 10, 2020
Amount Raised: $27,000,000
SLIPS Technologies

Cambridge, Massachusetts, United States

SLIPS Technologies (slipstechnologies.com) is the leader in providing customized solutions for sticky problems in materials

Advanced MaterialsBuilding MaterialChemical
Series BJun 20, 2017
Amount Raised: $5,650,000
Emulate

Boston, Massachusetts, United States

Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.

BiotechnologyHealth CareLife ScienceMedical
Series BOct 20, 2016
Amount Raised: $17,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator